primary antibodies against p21 (Cell Signaling Technology Inc)
Structured Review

Primary Antibodies Against P21, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against p21/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "Liver-bone organoids reveal senescence-driven interorgan crosstalk"
Article Title: Liver-bone organoids reveal senescence-driven interorgan crosstalk
Journal: Bioactive Materials
doi: 10.1016/j.bioactmat.2025.08.039
Figure Legend Snippet: Senescent bone organoids construction by replication. IHC staining of SA-β-gal in bone tissues (A) and primary BMSCs (B) of 4-month-old and 14-month-old mice. Scale bars, 200 μm and 100 μm. (C) Diagram of senescent bone organoids construction via 3D bioprinting. (D) Proliferation of P3 and P23 BMSCs. (E) IF staining of SA-β-gal in P3 and P23 BMSCs using a fluorescent probe (red). Scale bars, 100 μm. (F) IF staining of p21 (green), SA-β-gal (red), γ-H2A.X (purple) and DAPI (blue) in bone organoids constructed by P3 and P23 BMSCs. Scale bars, 200 μm. (G) Mineralization of bone organoids assessed by micro-CT scanning. (H–J) Changes and quantitative analysis of BMD (H), BV/TV (I) and Tb.Th (J). Data are presented as the mean ± SD. Data are considered statistically significant at ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001.
Techniques Used: Immunohistochemistry, Staining, Construct, Micro-CT
Figure Legend Snippet: Senescent bone organoids construction by inducer. (A) IHC staining of SA-β-gal in primary BMSCs treated with 0.5 μM DOX for 48 h. Scale bars, 50 μm. (B) Diagram of DOX-induced senescent bone organoids construction. (C–F) Represented images of 3D mineralization of bone organoids treated with 0.5 μM DOX for 3 and 6days (C) and quantification of BMD (D), BV/TV (E) and Tb.Th (F). (G–H) IF staining of p21 (green), SA-β-gal (red), γ-H2A.X (purple) and DAPI (blue) in bone organoids treated with 0.5 μM DOX (G), D-gal and H 2 O 2 (H). Scale bars, 200 μm. (I–L) Represented images of 3D mineralization of bone organoids treated with D-gal and H 2 O 2 for 6days (I) and quantification of BMD (J), BV/TV (K) and Tb.Th (L). Data are presented as the mean ± SD. Data are considered statistically significant at ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001.
Techniques Used: Immunohistochemistry, Staining
Figure Legend Snippet: Construction of senescent liver organoids. (A) IF staining of SA-β-gal in liver tissues of 4-month-old and 14-month-old mice. Scale bars, 200 μm. (B) Diagram of senescent liver organoids construction from aged mice. (C) IF staining of SA-β-gal in liver organoids constructed from the duct of 4-month-old and 14-month-old mice. Scale bars, 100 μm. (D) SA-β-gal detection in AML12 cells treated with 0.5 μM DOX for 24 h. Scale bars, 50 μm. (E) The protein level of p53, p21 and p16. (F) Relative mRNA levels of p21. (G) Diagram of DOX-induced senescent liver organoids construction. (H) IF staining of p21 (green), SA-β-gal (red), γ-H2A.X (purple) and DAPI (blue) in liver organoids treated with 0.5 μM DOX for 3 and 6 days. Scale bars, 100 μm. (I) Lipid accumulation of liver organoids. Scale bars, 100 μm. Data are presented as the mean ± SD. Data are considered statistically significant at ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001.
Techniques Used: Staining, Construct
Figure Legend Snippet: Senescence propagation between liver and bone organoids. (A–B) IF staining of senescence markers in liver organoids (SA-β-gal) (A) and bone organoids (p21, SA-β-gal and γ-H2A.X) (B) treated with 10 % serum (excluded FBS) from 4-month-old and 14-month-old mice. Scale bars, 100 μm and 200 μm. (C–F) Represented images of 3D mineralization (C) and quantification of BMD (D), BV/TV (E) and Tb.Th (F). (G) Diagram of the senescent conditioned medium exchange between liver and bone organoids. (H) IF staining of SA-β-gal in liver organoids treated with conditioned medium from senescent bone organoids. Scale bars, 100 μm. (I) IF staining of p21 (green), SA-β-gal (red), γ-H2A.X (purple) and DAPI (blue) in bone organoids treated with conditioned medium from senescent liver organoids. Scale bars, 200 μm. (J–M) Represented images of 3D mineralization (J) and quantification of BMD (K), BV/TV (L) and Tb.N (M). Data are presented as the mean ± SD. Data are considered statistically significant at ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001.
Techniques Used: Staining
Figure Legend Snippet: 27-hydroxycholesterol drives senescence propagation to bone organoids. (A) IF staining of senescence markers (p21, SA-β-gal and γ-H2A.X) in bone organoids treated with 2.5 μM 27- OHC for 6 days. Scale bars, 200 μm. (B–E) Represented images of 3D mineralization of bone organoids treated with DOX and 27-OHC (B) and quantitative analysis of BMD (C), BV/TV (D) and Tb.Th (E). (F) H&E, Masson's Trichrome and ARS staining of bone organoids treated with DOX and 27-OHC. Scale bars, 200 μm. 10-week-old male mice were administered the 27-OHC via intraperitoneal injection daily for 20 days after HDT PT3-NRAS and AKT along with transposase ( SB100 ) (n = 5 per group). (G–K) Represented images of 3D scanning (G) and quantification of BMD (H), BV/TV (I), Tb.N (J), and Tb.Sp (K). Data are presented as the mean ± SD. Data are considered statistically significant at ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001.
Techniques Used: Staining, Injection

